Why do some people live into their 90s or even past 100 while others develop age-related diseases much earlier?

Scientists have been studying this question for decades. Today, longevity research is no longer focused only on counting birthdays. Researchers are investigating biological aging—the gradual changes in cells, tissues, and organs that increase the risk of disease and loss of function.

The goal is increasingly to extend healthspan, meaning the number of years a person remains healthy and functional, rather than simply extending lifespan.

Scientists have identified many biological processes involved in aging, but there is still no proven treatment that can dramatically extend human lifespan.

What Determines How Long We Live?

Human lifespan is influenced by many factors.

Genetics, environment, behavior, socioeconomic conditions, medical care, infections, and random biological events can all affect survival.

Genetics clearly plays a role in exceptional longevity. Research has identified genetic variants and biological pathways associated with long and healthy lives. However, genes do not determine lifespan by themselves.

A large cohort study involving more than 350,000 people found that genetic predisposition and lifestyle were independently associated with lifespan. The researchers also found that healthier lifestyle patterns were associated with lower premature mortality across different genetic-risk groups.

This illustrates an important point: having certain genetic advantages does not make lifestyle and environmental factors irrelevant.

What Is Biological Aging?

Chronological age simply tells us how long someone has been alive.

Biological aging describes changes occurring inside the body.

Scientists study processes including:

• DNA damage and genomic instability

• Cellular senescence

• Mitochondrial dysfunction

• Changes in protein maintenance

• Chronic inflammation

• Altered nutrient sensing

• Stem-cell exhaustion

• Changes in cellular communication

These processes interact rather than operating independently. Researchers therefore increasingly view aging as a complex biological network rather than a single mechanism.

The Role of Metabolism

One of the most important areas of longevity research involves how cells sense and use nutrients.

Scientists study pathways including mTOR, AMPK, insulin/IGF-1 signaling, sirtuins, and NAD+ metabolism.

These pathways help cells respond to nutrients, energy availability, growth signals, and cellular stress.

One major research area is dietary restriction. Experiments in many organisms have shown that reducing energy intake under controlled conditions can influence lifespan and aging-related pathways.

However, findings from animals cannot automatically be translated into a recommendation for humans.

A 2026 review in Nature Aging highlighted ongoing research into dietary restriction, fasting, and potential "caloric restriction mimetics" that target pathways such as mTOR, AMPK, and autophagy.

Lifestyle and Longevity

Some of the strongest evidence for healthy aging comes from relatively ordinary behaviors rather than futuristic anti-aging treatments.

Not smoking, maintaining regular physical activity, eating a nutritious diet, getting adequate sleep, and controlling important health risks are associated with better health and lower risk of premature death.

This does not mean these behaviors guarantee a long life.

Rather, population research consistently shows relationships between healthier behaviors and better health outcomes.

Importantly, lifestyle effects can also vary between individuals because genetics, environment, existing disease, and other factors influence biological responses.

Cellular Senescence and Aging

Another major area of longevity research involves cellular senescence.

Senescent cells stop dividing but remain biologically active. They can have useful functions, such as helping prevent damaged cells from continuing to proliferate.

However, senescent cells can accumulate with age and release signaling molecules that influence surrounding tissues.

Scientists are studying senolytics, experimental treatments designed to selectively remove certain senescent cells.

In 2026, an NIH-supported research consortium produced the first comprehensive atlas of senescent cells across the human body. The work is helping researchers understand where these cells occur and how different types of senescence may influence health.

But this research does not mean that senolytic drugs have been proven to extend human lifespan.

That distinction is important.

What About Rapamycin?

Rapamycin is another major topic in longevity research.

It inhibits the mTOR pathway, which plays an important role in cellular growth and nutrient sensing.

In laboratory animals, rapamycin has produced some of the most reproducible lifespan-extension results among pharmacological interventions studied so far.

Human researchers are now investigating whether rapamycin or related drugs can improve aspects of aging and health.

However, researchers continue to study potential side effects, appropriate doses, and whether benefits seen in laboratory organisms translate into longer or healthier lives in humans. A 2026 review described rapamycin as promising but emphasized that its clinical longevity benefits in humans remain unresolved.

Can We Measure Biological Age?

Scientists are developing biological aging clocks that attempt to estimate biological age using measurements such as DNA methylation patterns, proteins, metabolites, and other biomarkers.

These tools can be useful for research because two people with the same chronological age can show different biological measurements.

But an important limitation remains: a biological-age clock is a measurement tool, not proof that an intervention has made someone biologically younger.

Recent research shows that different aging clocks can respond differently to interventions, highlighting the need for better validation before they are used as definitive measures of anti-aging effects.

What Scientists Still Don't Know

One of the biggest questions is whether aging can actually be slowed substantially in humans.

Scientists have identified many mechanisms associated with aging, but association does not automatically mean that changing a particular mechanism will extend human lifespan.

For example, an intervention might improve an aging-related biomarker without reducing disease or increasing lifespan.

Researchers also need to understand how aging differs between organs. A person's brain, immune system, muscles, heart, and kidneys may not age at exactly the same rate.

Recent genetic and molecular research is helping scientists identify pathways associated with longevity, but translating these discoveries into safe treatments remains difficult.

Are Anti-Aging Supplements the Answer?

The popularity of supplements marketed for longevity has grown rapidly.

Compounds such as NAD+ precursors, resveratrol, and various antioxidants have attracted considerable scientific and commercial interest.

But laboratory evidence is not the same as proof that a supplement makes humans live longer.

Human trials are often smaller, shorter, and more complicated than animal experiments. A supplement may change a biomarker without producing a meaningful improvement in health or lifespan.

This is why researchers increasingly emphasize controlled human clinical trials rather than laboratory results or marketing claims.

The Future of Longevity Research

The future of longevity science may involve combinations of approaches rather than one "anti-aging pill."

Researchers are investigating cellular senescence, metabolism, inflammation, mitochondrial function, regenerative medicine, genetics, epigenetics, and other biological pathways.

Artificial intelligence and large biological datasets may also help researchers identify relationships between genes, molecular pathways, aging biomarkers, and disease.

The ultimate goal is to understand which biological changes actually drive age-related decline—and determine whether they can be modified safely.

Conclusion

The science of longevity has moved far beyond the idea that aging is simply the passage of time.

Researchers now understand that aging involves interconnected changes in DNA, cells, metabolism, immune function, mitochondria, protein maintenance, and tissue repair.

Some findings are well established. Regular healthy behaviors are associated with better health and lower premature mortality, and genetics contributes to differences in longevity.

Other areas—including senolytics, rapamycin, biological-age clocks, and many dietary or pharmaceutical interventions—remain active areas of research.

The biggest challenge is turning promising laboratory discoveries into treatments that reliably improve human healthspan and, ultimately, lifespan.

For now, the science supports a cautious conclusion: we understand considerably more about why organisms age, but the idea of dramatically extending human life remains an open scientific question.

Frequently Asked Questions

1. What is the difference between lifespan and healthspan?

Lifespan is the total length of a person's life. Healthspan refers to the period of life spent in relatively good health and functional ability. Modern aging research increasingly focuses on extending healthspan rather than simply adding years.

2. Do genes determine how long a person will live?

No. Genetics influences longevity, but lifespan also depends on environmental exposures, health behaviors, medical care, socioeconomic factors, and other biological and random factors. Research indicates that genetic and lifestyle factors can independently influence lifespan.

3. Can scientists currently reverse human aging?

There is currently no established treatment that reverses normal human aging or dramatically extends human lifespan. Several interventions have shown promising effects in laboratory organisms, but translating those findings into safe, effective human treatments remains a major research challenge.

4. What are senolytics?

Senolytics are experimental drugs designed to selectively eliminate certain senescent cells. Researchers are investigating whether removing harmful senescent cells could improve aspects of age-related health, but their ability to extend human lifespan has not been established.

5. Do biological-age tests tell you how long you will live?

No. Biological-age clocks can provide research measurements of aging-related biological patterns, but they are not reliable crystal balls for predicting an individual's lifespan. Researchers are still evaluating which biomarkers best reflect meaningful changes in health and aging.